Pitch deck | Pharma
1k
5.9k
34
Published:

Pitch deck | Pharma

The Israeli startup. KILLEVIR’s molecular biologists 
introduce unique anti-HIV mono-therapy drug, 
based on by Fullerene-poly-aminocaproic acid. Read More
1k
5.9k
34
Published: